N Engl J Med 2023; 389:877-888DOI: 10.1056/NEJMoa2302392 Abstract BACKGROUND Obesity is a major risk factor for many leading causes of illness and death worldwide. Data are needed regarding the efficacy and safety of the nonpeptide glucagon-like peptide-1 (GLP-1)...
https://doi.org/10.1016/j.abd.2022.09.006 Abstract Female androgenetic alopecia or female-pattern hair loss (FPHL) is highly prevalent and has a great impact on the quality of life. The treatment is a routine challenge in dermatological practice, as many therapeutic...
PMID: 35032336 DOI: 10.1111/jocd.14773 Abstract Female pattern hair loss (FPHL) is the most common form of alopecia in women. FPHL may compromise body image and strongly affect self-esteem, negatively impacting quality of life. Currently, the only Food and...
Retatrutide, an experimental obesity drug from Eli Lilly, harnesses three hormones to control eating and could “someday” lead to similar levels of weight loss that are seen with bariatric surgery. Patients taking Eli Lilly’s retatrutide lost 58 pounds, on average, in...
PMID: 19250003 PMCID: PMC2894814 DOI: 10.1089/acm.2008.0410 Abstract Objectives: Intravenous micronutrient therapy (IVMT), and specifically the Myers’ Cocktail, is a popular approach for treating fibromyalgia syndrome (FMS) among...
DOI:https://doi.org/10.1016/j.ebiom.2018.09.015 Abstract Background Senescence is a tumor suppressor mechanism activated in stressed cells to prevent replication of damaged DNA. Senescent cells have been demonstrated to play a causal role in driving aging and...
